# Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

> **NCT07487077** · PHASE4 · RECRUITING · sponsor: **Albert B. Sabin Vaccine Institute** · enrollment: 1071 (estimated)

## Conditions studied

- Cholera Vaccination

## Interventions

- **DRUG:** Euvichol-S Oral Cholera Vaccine

## Key facts

- **NCT ID:** NCT07487077
- **Lead sponsor:** Albert B. Sabin Vaccine Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 1071 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07487077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07487077, "Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07487077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*